References

Trends in peptide drug discovery

10.1038/s41573-020-00135-8 · 2021 · External reference

Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations

10.1124/dmd.123.001437 · 2023 · External reference

Therapeutic peptides: current applications and future directions

10.1038/s41392-022-00904-4 · 2022 · External reference

Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds

10.1016/j.xphs.2023.05.006 · 2023 · External reference

Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma

10.1016/j.bbrc.2023.02.021 · 2023 · External reference

Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis

10.1016/j.xphs.2018.10.011 · 2019 · External reference

Cyclosporin: measurement of fraction unbound in plasma

10.1111/j.2042-7158.1987.tb03436.x · 1987 · External reference

Clinical Pharmacokinetics of Daptomycin

10.1007/s40262-020-00968-x · 2021 · External reference

Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects

10.1002/cpdd.717 · 2020 · External reference

Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats

10.1021/acs.jnatprod.6b01176 · 2017 · External reference

Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health

10.1111/j.1365-2125.1985.tb05107.x · 1985 · External reference